AARON KANTOFF

Profile

First Name

: AARON

Middle Name

:

Last Name

: KANTOFF

Related Companies
Titles
Company Name
Related People
DIRECTOR
CURE FORWARD CORP.
PRESTON BRICE, LAUREN FARRELL, SETH HARRISON, STEVE HAU, FRANK INGARI, MARTIN NALEY, STEPHANIE PAPES
DIRECTOR
SYNTIMMUNE, INC.
BURT ADELMAN, M.D., LAURENCE BLUMBERG, M.D., RICHARD BLUMBERG, M.D., DAVID DE GRAAF, PH.D., SAM HALL, SAM HALL, PH.D., SETH HARRISON, SETH HARRISON, M.D., GEETA VEMURI
DIRECTOR
CORVIDIA THERAPEUTICS, INC.
RAM AIYAR, MARC DE GARIDEL, SYLVIE GREGOIRE, KARIM HELMY, TYRELL RIVERS, GRAZIANO SEGHEZZI
DIRECTOR
AKERO THERAPEUTICS, INC.
KEVIN BITTERMAN, ANDREW CHENG, MARK IWICKI, AARON ROYSTON, GRAHAM WALMSLEY, JONATHAN YOUNG
DIRECTOR
RAYZEBIO, INC.
DEBORAH CHARYCH, JEREL DAVIS, AUBREY HADDACH, MAHA KATABI, BONG KOH, ARVIND KUSH, YI LARSON, ALEX ROSEN, AARON ROYSTON, KEN SONG, MARY TAGLIAFERRI, ANGIE YOU
DIRECTOR
CEPTUR THERAPEUTICS, INC.
D. JAMES BALLANCE, CYNTHIA DAVIS, PAIMAN PETER GHOROGHCHIAN, RAFAL GORACZNIAK, SAMUEL GUNDERSON, SAMUEL I. GUNDERSON, DANIEL HELLER
EXECUTIVE OFFICER, PROMOTER
PETRICHOR SCION THERAPEUTICS LLC
SAMUEL W. HALL, TADD WESSEL
DIRECTOR
AVALO THERAPEUTICS, INC.
THOMAS AASEN, JUNE ALMENOFF, M.D., PH.D., SOL BARER, SOL J. BARER, EUGENE BAUER, EUGENE A. BAUER, ISAAC BLECH, JOHN CATSIMATIDIS, MITCHELL CHAN, BERNADINE HEATHER FRASER, JONATHAN GOLDMAN, M.D., PHIL GUTRY, ULI HACKSELL, JOHN KAISER, GILLA KAPLAN, PH.D., KAREN KRUMEICH, RONALD MARCUS, REZA MAZHARI, MARIAM MORRIS, MARIAM E MORRIS, GARRY NEIL, M.D., FEDERICA F. O-BRIEN, BLAKE M. PATERSON, MAGNUS PERSSON, MAGNUS PERSSON, M.D., PH.D., SHARON ROWLAND, BEHSHAD SHELDON, CARY SUCOFF, CARY W. SUCOFF, JR., MAYUKH SUKHATME, CHRISTOPHER SULLIVAN, FRANK TORTI, SAMANTHA TRUEX, JAMES VORNOV
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2024-04-09
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2024-03-27 
2023-03-15
D/A
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
 
2022-01-21 
2022-09-22
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2022-08-25 
2022-03-09
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-12-22 
2021-06-10
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-06-08 
2020-12-01
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-11-23 
2020-11-09
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-08-05 
2018-12-18
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2018-12-10 
2018-05-01
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-04-18 
2017-06-28
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-06-19 
2017-05-18
D/A
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-12-16 
2016-12-20
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-12-16 
2016-09-29
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-09-19 
2015-06-22
D/A
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-10-24 
2015-06-22
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-06-09 
2014-11-14
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-10-24